Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ascendis Pharma (ASND)
NASDAQ:ASND
Holding ASND?
Track your performance easily
See the Price Targets and Ratings of:
ASND Analyst Ratings
Strong Buy
13 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ASND Stock 12 Month Forecast
Average Price Target
$193.57
▲(55.69% Upside)
| Highest Price Target$289.00 | Average Price Target$193.57 | Lowest Price Target$160.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Wells Fargo
Reiterated
11/04/24
Bank of America Securities
Reiterated
11/04/24
Morgan Stanley
Reiterated
11/04/24
Cantor Fitzgerald
Reiterated
11/04/24
Wedbush
Initiated
11/04/24
J.P. Morgan
Reiterated
10/23/24
TD Cowen
Assigned
10/21/24
Oppenheimer
Reiterated
09/17/24
Leerink Partners
Reiterated
09/16/24
Stifel Nicolaus
Reiterated
09/16/24
Goldman Sachs
$180→$200
Buy
60.86%
Upside
Reiterated
09/16/24
Ascendis Pharma Receives Buy Rating Amid Positive Phase 3 Results for TransCon CNP
Citi
$178→$207
Buy
66.49%
Upside
Reiterated
09/16/24
Buy Rating on Ascendis Pharma as TransCon CNP Triumphs in Trials, with Raised Target Price to $207
Jefferies
$179
Buy
43.97%
Upside
Assigned
09/16/24
Ascendis Pharma (ASND) PT Raised to $179 at JefferiesJefferies analyst Kelly Shi raised the price target on Ascendis Pharma (NASDAQ: ASND) to $179.00 (from $174.00) while maintaining a Buy rating.
―
Evercore ISI
―
Buy
―
Reiterated
09/17/24
We think investors were assigning a ~1in3 probability of scenario #1 and 2in3 PoS of scenario #2. Stepping back, fundamentally, we would’ve argued there was 0 value in the stock for CNP at all, so despite yesterday’s +17% move we still like the setup on ASND mainly for the PTH launch in 2025. New PT = $205/sh w/ $450M in risk-adj TransCON CNP sales.
Best Analysts Covering Ascendis Pharma
Which Analyst Should I Follow If I Want to Buy ASND and Sell After:
1 Month
xxx
Success Rate
19/26 ratings generated profit
Average Return
+3.90%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 73.08% of your transactions generating a profit, with an average return of +3.90% per trade.
3 Months
xxx
Success Rate
9/13 ratings generated profit
Average Return
+9.96%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 69.23% of your transactions generating a profit, with an average return of +9.96% per trade.
1 Year
Success Rate
16/27 ratings generated profit
Average Return
+21.05%
reiterated a buy rating 18 days ago
Copying Jessica Fye's trades and holding each position for 1 Year would result in 59.26% of your transactions generating a profit, with an average return of +21.05% per trade.
2 Years
xxx
Success Rate
18/22 ratings generated profit
Average Return
+22.78%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 81.82% of your transactions generating a profit, with an average return of +22.78% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ASND Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
3
4
12
11
10
Buy
17
8
23
25
23
Hold
11
11
11
10
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
31
23
46
46
40
Each month's total comprises the sum of three months' worth of ratings.
ASND Financial Forecast
ASND Stock Forecast FAQ
What is ASND’s average 12-month price target, according to analysts?
Based on analyst ratings, Ascendis Pharma’s 12-month average price target is $193.57.
What is ASND’s upside potential, based on the analysts’ average price target?
Ascendis Pharma has 55.69% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ASND a Buy, Sell or Hold?
Ascendis Pharma has a consensus rating of Strong Buy which is based on 13 buy ratings, 1 hold ratings and 0 sell ratings.
What is Ascendis Pharma’s price target?
The average price target for Ascendis Pharma is $193.57. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $289.00 ,the lowest forecast is $160.00. The average price target represents 55.69% Increase from the current price of $124.33.
The highest analyst price target is $289.00 ,the lowest forecast is $160.00. The average price target represents 55.69% Increase from the current price of $124.33.
What do analysts say about Ascendis Pharma?
Ascendis Pharma’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of ASND?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.